BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND PPP2R1A, PR65A, 5518, ENSG00000105568, MGC786, P30153 AND Prognosis
8 results:

  • 1. Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset.
    Hong JH; Cho HW; Ouh YT; Lee JK; Chun Y; Gim JA
    J Gynecol Oncol; 2022 May; 33(3):e29. PubMed ID: 35128859
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. uterine serous carcinoma: key advances and novel treatment approaches.
    Ferriss JS; Erickson BK; Shih IM; Fader AN
    Int J Gynecol Cancer; 2021 Aug; 31(8):1165-1174. PubMed ID: 34210768
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. uterine serous carcinoma.
    Bogani G; Ray-Coquard I; Concin N; Ngoi NYL; Morice P; Enomoto T; Takehara K; Denys H; Nout RA; Lorusso D; Vaughan MM; Bini M; Takano M; Provencher D; Indini A; Sagae S; Wimberger P; Póka R; Segev Y; Kim SI; Candido Dos Reis FJ; Lopez S; Mariani A; Leitao MM; Raspagliesi F; Panici PB; Di Donato V; Muzii L; Colombo N; Scambia G; Pignata S; Monk BJ
    Gynecol Oncol; 2021 Jul; 162(1):226-234. PubMed ID: 33934848
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.
    Le Gallo M; Rudd ML; Urick ME; Hansen NF; Zhang S; ; Lozy F; Sgroi DC; Vidal Bel A; Matias-Guiu X; Broaddus RR; Lu KH; Levine DA; Mutch DG; Goodfellow PJ; Salvesen HB; Mullikin JC; Bell DW
    Cancer; 2017 Sep; 123(17):3261-3268. PubMed ID: 28485815
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Selected Immunohistochemical Panel Aids in Differential Diagnosis and Prognostic Stratification of Subtypes of High-grade Endometrial Carcinoma: A Clinicopathologic and Immunohistochemical Study at a Single Institution.
    Taskin OÇ; Onder S; Topuz S; Sozen H; Sen F; Ilhan R; Yavuz E
    Appl Immunohistochem Mol Morphol; 2017; 25(10):696-702. PubMed ID: 27093454
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.
    Stelloo E; Bosse T; Nout RA; MacKay HJ; Church DN; Nijman HW; Leary A; Edmondson RJ; Powell ME; Crosbie EJ; Kitchener HC; Mileshkin L; Pollock PM; Smit VT; Creutzberg CL
    Mod Pathol; 2015 Jun; 28(6):836-44. PubMed ID: 25720322
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Endometriosis-related ovarian tumors].
    Schmidt D; Ulrich U
    Pathologe; 2014 Jul; 35(4):348-54. PubMed ID: 24992974
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ppp2r1a mutations are common in the serous type of endometrial cancer.
    Nagendra DC; Burke J; Maxwell GL; Risinger JI
    Mol Carcinog; 2012 Oct; 51(10):826-31. PubMed ID: 21882256
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.